臉部注射劑市場規模、佔有率、成長分析、按產品、按應用、按最終用途、按地區 - 行業預測，2024-2031 年

2022年全球臉部注射劑市場規模為101億美元，從2023年的113.1億美元成長到2031年的280.1億美元，預測期（2024-2031）預計複合年成長率為12.00%。

在臉部美容需求不斷成長的推動下，全球臉部注射劑市場將在未來幾年顯著成長。該領域包括專為美容療程而設計的注射物質的生產、分銷和應用，主要是抗皺、恢復臉部體積和改善整體皮膚外觀。這個市場主要圍繞著兩種主要技術：肉毒桿菌注射和皮膚填充劑，這兩種技術都能增加皮膚光澤和水合作用，從而改善質地。隨著消費者對臉部化妝品越來越感興趣，加上年輕人可支配收入迅速增加，美容化妝品支出有望轉正。值得注意的是，在消費者對美容趨勢的參與推動下，美國臉部注射劑市場預計將在未來的預測期內實現永續的年複合成長率(CAGR)，反映出更廣泛的成長趨勢。由於社會對外表和自我護理的日益關注，臉部注射劑市場預計將繼續擴大，使其成為美容和健康行業投資和創新的關鍵領域。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 技術分析
• 價格分析
• 價值鏈分析
• 市場生態系統
• 貿易分析
• 供應鏈分析
• 案例研究分析
• 專利分析
• 客戶和購買標準分析
• 監管環境
• 創新矩陣
• 主要投資分析
• 關鍵成功因素
• 競爭程度

臉部注射劑市場：按產品

• 市場概況
• 膠原蛋白和 PMMA 微球
• 透明質酸（HA）
• A型肉毒桿菌毒素
• 烴基磷灰石鈣(CaHA)
• 聚左旋乳酸(PLLA)
• 其他

臉部注射劑市場：依應用分類

• 市場概況
• 臉部線條矯正
• 豐唇術
• 拉皮
• 痤瘡疤痕治療
• 脂肪萎縮的治療
• 其他

臉部注射劑市場：依最終用途分類

• 市場概況
• 梅迪斯帕
• 皮膚科診所
• 醫院

臉部注射劑市場規模：按地區分類

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Ispen（France）
• Abbvie（US）
• Medytox Inc.（South Korea）
• Merz GmbH and Co. KGaA（Germany）
• Revance Therapeutics, Inc.（US）
• Galderma（Switzerland）
• Sinclair Pharma（UK）
• Allergan Aesthetics（a subsidiary of AbbVie）（US）
• Hugel, Inc.（South Korea）
• Sientra, Inc.（US）
• Revance Therapeutics, Inc.（US）
• Evolus, Inc.（US）
• Medytox Inc.（South Korea）
• Hugel, Inc.（South Korea）
• AptarGroup, Inc.（US）
• Ipsen SA（France）
• Galderma SA（Switzerland）
• Revanesse（Canada）
• Merz North America（US）
• Suneva Medical, Inc.（US）
• Aesthetic Medical International Holdings Group（China）
• Neauvia（Switzerland）

Global Facial Injectables Market size was valued at USD 10.1 billion in 2022 and is poised to grow from USD 11.31 billion in 2023 to USD 28.01 billion by 2031, growing at a CAGR of 12.00% during the forecast period (2024-2031).

The global facial injectables market is set for substantial growth in the coming years, driven by an increasing demand for facial aesthetic enhancements. This sector encompasses the production, distribution, and application of injectable substances specifically designed for aesthetic treatments, primarily focusing on anti-aging solutions that reduce wrinkles, restore facial volume, and improve overall skin appearance. The market primarily revolves around two key methodologies: botulinum toxin injections and dermal fillers, both of which enhance skin glow and moisture retention, leading to improved texture. As consumer interest in facial cosmetics rises, coupled with a surge in disposable income among younger demographics, spending on beauty and cosmetic products is expected to see a positive uptick. Notably, the U.S. facial injectables market is anticipated to achieve a sustainable compound annual growth rate (CAGR) in the upcoming forecast period, reflecting the broader trend of increased consumer engagement with aesthetic treatments. The growing societal emphasis on appearance and self-care is further positioning the facial injectables market for continued expansion, making it a key area for investment and innovation within the beauty and wellness industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Facial Injectables market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Facial Injectables Market Segmental Analysis

Global Facial Injectables Market is segmented by Product, Application, End-use and region. Based on component, the market is segmented into Collagen & PMMA Microspheres, Hyaluronic Acid (HA), Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), Poly-L-lactic Acid (PLLA), and Others. Based on Application, the market is segmented into Facial Line Correction, Lip Augmentation, Face Lift, Acne Scar Treatment, Lipoatrophy Treatment, and Others. Based on End-use, the market is segmented into MedSpas, Dermatology Clinics, Hospitals. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Facial Injectables Market

The Global Facial Injectables market is poised for substantial growth, driven by the escalating consumer demand for non-invasive aesthetic solutions, particularly among the Millennial demographic, who increasingly favor facial injectables to address skin damage caused by environmental factors and lifestyle choices. With products like collagen fibers, hyaluronic acid fillers, and synthetic injectables, consumers are attracted to the dual benefits of hydration and UV protection, alongside minimal side effects. Additionally, rising disposable incomes and advancements in technology, which enhance safety by reducing infection risks and procedure costs, are further fueling the market's expansion during the forecast period.

Restraints in the Global Facial Injectables Market

The Global Facial Injectables market faces several market restraints that limit its expansion. Stringent regulatory requirements and limitations concerning product approval create barriers to entry and complicate the commercialization of new solutions. Additionally, skin-related side effects such as rashes and redness discourage potential consumers from seeking these treatments, especially as safety concerns grow. High costs associated with fillers can also deter patients from opting for facial injectables, while the lack of insurance coverage for aesthetic procedures further exacerbates the issue, restricting market growth. Together, these factors create a challenging environment for the advancement of the global facial injectables industry.

Market Trends of the Global Facial Injectables Market

The Global Facial Injectables market is witnessing a significant trend fueled by the rising acceptance of these cosmetic treatments among the male population. As more men seek anti-aging solutions, the adoption of dermal fillers and botulinum toxin is on the rise, reflecting a shift in societal norms around male aesthetics. Young males, in particular, are increasingly inclined towards tissue fillers for rejuvenation purposes, further driving this trend. Additionally, hyaluronic acid fillers are gaining traction due to their efficacy in anti-aging treatments, propelling market growth. This evolving landscape indicates a broader demographic embracing facial injectables, expanding the market's potential.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Trade Analysis
• Supply chain Analysis
• Case study Analysis
• Patent Analysis
• Customer & Buying Criteria Analysis
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Facial Injectables Market by Product

• Market Overview
• Collagen & PMMA Microspheres
• Hyaluronic Acid (HA)
• Botulinum Toxin Type A
• Calcium Hydroxylapatite (CaHA)
• Poly-L-lactic Acid (PLLA)
• Others

Facial Injectables Market by Application

• Market Overview
• Facial Line Correction
• Lip Augmentation
• Face Lift
• Acne Scar Treatment
• Lipoatrophy Treatment
• Others

Facial Injectables Market by End-use

• Market Overview
• MedSpas
• Dermatology Clinics
• Hospitals

Facial Injectables Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Ispen (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbvie (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medytox Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merz GmbH and Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revance Therapeutics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Galderma (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sinclair Pharma (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergan Aesthetics (a subsidiary of AbbVie) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hugel, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sientra, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revance Therapeutics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evolus, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medytox Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hugel, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AptarGroup, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ipsen S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Galderma S.A. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revanesse (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merz North America (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Suneva Medical, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aesthetic Medical International Holdings Group (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neauvia (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments